Status:
COMPLETED
rTMS Treatment of Primary Progressive Aphasia
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Primary Progressive Aphasia
Repetitive Transcranical Magnetic Stimulation
Eligibility:
All Genders
35-75 years
Phase:
NA
Brief Summary
Primary Progressive Aphasia (PPA) is a neurodegenerative disease in which language function is gradually and progressively impaired. Patients will eventually be disabled in communication and have cogn...
Eligibility Criteria
Inclusion
- Clinical diagnosis of PPA
Exclusion
- Scored below 15 on the mini-mental state exam (MMSE)
- history of seizures or unexplained loss of consciousness
- pregnancy
- surgical breach of the skull
- MRI contraindication
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04431401
Start Date
July 1 2020
End Date
August 31 2022
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730